Calls Now Open
2022 ADDF-Harrington and 2023 Harrington UK Rare Disease Programs
This Center focuses on rare, ultra-rare and rare variants of common diseases.
The University of Oxford and Harrington Discovery Institute have formed a unique partnership combining world-leading strengths in research and therapeutics development. The Oxford-Harrington Centre will advance knowledge into cures for rare diseases across the United Kingdom and the United States.
Professor Matthew Wood
Director, Oxford-Harrington Rare Disease Centre; Professor of Neuroscience, University of Oxford
Chief Scientific Officer, Harrington Discovery Institute, Chief Academic Officer, University Hospitals Health System; Chief Research Officer, University Hospitals Harrington Heart and Vascular Institute; the Ellery Sedgwick Jr. Chair and Distinguished Scientist, Vice Dean for Academic Affairs, and Vice Dean for Medical Sciences, and Professor of Medicine, Case Western Reserve University School of Medicine
Sir John Bell
Regius Professor of Medicine, University of Oxford
Georg Holländer, MD
Head of Department of Paediatrics, University of Oxford
Jonathan S. Stamler, MD
President, Harrington Discovery Institute
Supports UK researchers in the development of cures and therapies for rare disease.
